Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.37 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | GRN | P28799 | 3/20 | 0.36 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.36 |
| ▸ | MARS1 | P56192 | 1/20 | 0.36 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.36 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL209212 | 0.75 | TLR8 (0.45) | CA12CA1CA2CA9 | |
| SCHEMBL4692297 | 0.73 | PPARG (0.57) | LMNAGRNSORT1MARS1 | |
| SCHEMBL5251027 | 0.72 | LMNA (0.45) | LMNARAB9AMEN1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL10712022 | 0.70 | GRN (0.40) | RAB9AMEN1KMT2ASMN1; SMN2GRN | |
| SCHEMBL4310512 | 0.69 | GRN (0.59) | GRNSORT1KDM4E | |
| SCHEMBL1739252 | 0.69 | ALPL (0.46) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL17593153 | 0.65 | SMN1; SMN2 (0.56) | CA12CA1CA2CA9RAB9A | |
| SCHEMBL27687138 | 0.64 | SMN1; SMN2 (0.69) | LMNAMEN1KMT2ASMN1; SMN2GRN | |
| SCHEMBL4739140 | 0.63 | KMT2A (0.45) | LMNACA12CA1CA2CA9 | |
| SCHEMBL10608666 | 0.63 | ALDH1A1 (0.56) | LMNAHPGDL3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1926713-B1 | PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECH CORP (US) | 2013-04-10 | — | — | EP | claimed |
| US-20140264166-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130264519-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2013-10-10 | — | — | US | disclosed |
| US-8470052-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2013-06-25 | — | — | US | disclosed |
| EP-1926713-B1 | PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECH CORP (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20120118109-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2012-05-17 | — | — | US | disclosed |
| US-8088810-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20080312452-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2008-12-18 | — | — | US | disclosed |
| EP-1926713-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007040817-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312452-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | PRMT9, CHD9, CYP2C9 | LMNA 1792/4885CA12 1372/4885CA1 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.